Steven Cohen’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
6CM
Steven Cohen's PHAT Position: Q3 2026 in Review
Steven Cohen increased its Phathom Pharmaceuticals (PHAT) stake by 47% in Q3 2026, buying an estimated $4.52M and bringing the position to 1,501,268 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #1299.
Steven Cohen first reported a position in PHAT in Q1 2023 and has held it in 4 quarters since. The position peaked at $11.1M in Q2 2026. 159 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.
- Steven Cohen held 1,501,268 shares of Phathom Pharmaceuticals worth $11M as of Q3 2026.
- Steven Cohen bought 479,075 Phathom Pharmaceuticals shares in Q3 2026, an estimated $4.52M.
- Phathom Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1299 holding.
- Steven Cohen first reported a position in Phathom Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
- Steven Cohen's Phathom Pharmaceuticals position peaked at $11.1M in Q2 2026.
- 159 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.